Home / Guides / Free RS Rating tools

Free RS Rating Tools Compared

Author: RPS Research Desk (RPS Stock Editorial Team) · About this site, data sources and methodology · Editing and correction standards

📅 Updated: 🕐 Reading time: about 8 min 📊 Free tools · neutral comparison

⚡ Quick answer (Speakable)

Free RS Rating tools differ in market coverage, calculation method, and access. For US stocks, options observed include Shibui, MarketInOut, Tweevest, and the ibd-rs-rating Python package. RPS Stock offers a free A-share plan with RPS90; its other markets and periods are included in paid plans.

🤖 Short summary (TL;DR)

“Free RS Rating” can mean a free screener, a free list, an early-access tool, or an open-source package—not necessarily the proprietary IBD RS Rating. Compare each tool’s stated method and market coverage. As stated on the RPS Stock homepage on 2026-11-02, it covers A-shares, US, Hong Kong, and Japan; its free plan is limited to A-shares and RPS90.

⚠️ Method boundaries (read first)

What does “free RS Rating” mean?

“RS Rating” is used for tools that rank or screen stocks by relative strength, but the label alone does not tell you how the measure is calculated. Providers may state different methods, time windows, universes, and access conditions. A free tool may provide a screener, a filtered list, early access, or a software package rather than the same product or data as another provider.

Some services describe a measure as IBD-style or O’Neil-style. That wording is not proof that the result is the proprietary IBD RS Rating. For a comparison of the terms and approaches, see IBD RS Rating vs. RPS and what RPS means. RS Rating also should not be confused with RSI; they are different measures, as explained in RPS vs. RSI.

Free RS Rating tools for US stocks

The table summarizes provider-stated details and observations made on 2026-11-02. Coverage and method descriptions are not directly interchangeable: each provider defines its own scope.

ToolCost/access statedCoverageMethod or stated scopeCaveat / observation
ShibuiFree screener10,000+ US stocksO’Neil-style 1–99; stated weighting of 40/20/20/20Its page says the measure is not the proprietary IBD RS Rating. Page last updated 2026-09-23; details observed 2026-11-02.
MarketInOutFree RS 80+ listNYSE and NasdaqLabels its measure rs(252)Page stated data as of Oct 30, 2026; displayed 1,294 matches when observed 2026-11-02.
TweevestFree early accessUS stocksRS Rating/EPS CANSLIM screenerAs observed on 2026-11-02. Live recheck was blocked by an HTTP 429/Vercel security checkpoint, so details were not independently rechecked.
ibd-rs-rating (PyPI)Package listed on PyPI; the project page does not state a priceAbout 4,600 US stocks, as described by the projectUnofficial IBD-style relative strength rating; description says percentile-ranked 1–99PyPI showed version 0.5.0 when observed on 2026-11-02. It is not an official IBD product.
RPS StockFree CNY 0: A-share RPS90 only (pricing page, updated Oct 27, 2026). Premium CNY 29/mo or CNY 199/yr; VIP CNY 69/mo or CNY 499/yr. Amounts are Chinese yuan, not Japanese yenA-shares 5,212; US 9,014; Hong Kong 2,760; Japan 3,681 (homepage RPS50 effective sample, 2026-11-06 snapshot, rechecked 2026-11-07)Multi-period RPS20/50/90/120/250 in-market percentile ranks; updated after closeDescribes its own RPS percentiles, not an official IBD RS Rating. Verify current plan details on the pricing page.

Shibui’s page quotes MarketSmith at $149.95/month as of the Shibui page content observed 2026-11-02. That figure is a third-party quote on Shibui’s page and was not independently verified here as current MarketSmith pricing.

These descriptions reflect what the providers or project page stated, not a claim that the tools share a formula. For example, MarketInOut states rs(252), while Shibui describes an O’Neil-style weighted rating. See our RPS tools comparison for more context on the distinction between tools and measures.

What if I want Hong Kong, Japan, or A-shares?

The US-focused options in the table do not establish coverage for other markets. RPS Stock’s homepage lists an RPS50 effective sample of 5,212 A-shares, 9,014 US stocks, 2,760 Hong Kong stocks and 3,681 Japanese stocks (2026-11-06 snapshot, rechecked 2026-11-07).

RPS Stock’s pricing page, updated Oct 27, 2026, listed a free plan at CNY 0 for A-shares and RPS90. It listed Premium at CNY 29 per month or CNY 199 per year for A-shares, Hong Kong, US, and Japan across all periods, and VIP at CNY 69 per month or CNY 499 per year. These amounts are Chinese yuan (CNY), not Japanese yen. Check the pricing page for current plan details. For an explanation of the calculation, see how RPS is calculated.

Market coverage and plan details are provider-stated and time-sensitive. RPS Stock coverage figures above were rechecked on 2026-11-07; other providers’ details reflect 2026-11-02 observations; they are not a guarantee of future coverage or availability.

If you want to compare RPS across markets and periods, see RPS Stock’s current plans.

How to choose a tool

Start with the task you need the tool to perform, then check its stated scope:

For related terminology, see RS Rating vs. RS Line and relative strength and RPS. If you are looking for TradingView-related guidance, see our TradingView RS Rating and RPS guide; the available observation here is limited to autocomplete-related evidence.

Bottom line

There is no single definition of a free RS Rating tool. Compare the stated method, stock universe, market coverage, and access conditions rather than relying on the name alone. For an overview of stocks shown on RPS Stock, see strong stocks; it is a screening resource, not a recommendation.

Frequently asked questions (FAQ)

Is a free RS Rating the same as IBD’s proprietary rating?

No. A free tool’s RS measure should not be assumed to be IBD’s proprietary rating or an official IBD product. Shibui says its rating is not proprietary IBD, and ibd-rs-rating describes itself as unofficial.

Is RS Rating the same as RSI?

No. RS Rating and RPS refer to relative-strength measures, while RSI is a different indicator. See RPS vs. RSI for more detail.

Which free tools in this comparison cover markets outside the US?

RPS Stock describes coverage of A-shares, the US, Hong Kong, and Japan. Its free offering covers A-share RPS90. The other observed free tools in this comparison—Shibui, MarketInOut, Tweevest, and ibd-rs-rating—were US-only.

Can I use these tools to screen for CANSLIM stocks?

Tweevest was observed on 2026-11-02 as a free, early-access US CANSLIM RS/EPS screener. This describes the tool’s stated screening scope and is not investment advice.

Does RPS Stock provide the official IBD RS Rating?

No. RPS Stock describes its own multi-period RPS percentiles; these are not the official IBD RS Rating.

Compare RPS Stock plans

If you want to compare RPS across markets and periods, see RPS Stock’s current plans. Review the plan details to decide whether they fit your needs.

See current plans

Related pages

Open the multi-market RPS research tool

Full rankings for Hong Kong, U.S., and Japanese stocks require a membership plan. You can first review plan coverage (no pressure, no false urgency).

Plans and pricing

View plans

Related tool page: Free A-share RPS90 tool